Abstract
Tc-99m PMT and Tc-99m GSA can be taken up by hepatocellular carcinoma (HCC), but there has been no report concerning HCC showing accumulation of both of Tc-99m PMT and Tc-99m GSA. In this paper we describe a case of two simultaneously developed HCCs, one of which took up both tracers but the other took up neither of them.
Similar content being viewed by others
References
Shimomura O, Takahashi M, Tsuji A, Takagi Y, Tomiguchi S, Koga Y, et al. Evaluation of hepatic function by hepatobiliary scintigraphy using factor analysis.KAKU IGAKU (Jpn J Nucl Med) 26: 145–153, 1989.
Gon J, Nakagawa T, Maeda H, Nakamura H, Tashiro T, Matsuoka Y, et al. Evaluation of postoperative hapatobiliary function by deconvolution analysis of hepatobiliary image data by99mTc-N-pyridoxyl-5-methyltryptophan.Radioisotopes 37: 7–14, 1988.
Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, et al. Clinical usefulness of scintigraphy with99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver.J Nucl Med 40: 1652–1656, 1999.
Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage.Am J Gastoenterol 87: 865–870, 1992.
Hasegawa Y, Nakano S, Ishiguro S, Imaoka S, Sasaki Y, Tanaka S, et al. Comparison of delayed hepatobiliary imaging using99mTc-Sn-N-5-methyltryptophan and67Ga-citrate imaging for diagnosis of hepatocellular carcinoma.Eur J Nucl Med 14: 414–418, 1988.
Saito K, Koizumi K, Abe K, Goto Y, Seki T. Potential for qualitative diagnosis of tumors and tumorous lesions in the liver with Tc-99m-GSA SPECT-correlation with pathological evaluation and MRI findings.Ann Nucl Med 12: 275–280, 1998.
Hasegawa Y, Nakano S, Hiyama T, Sobue T, Yoshida H, Sasaki Y, et al. Relationship of uptake of Technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.J Nucl Med 32: 228–235, 1991.
Azuma-kato M. Tc-99m(Sn)-N-Pyridoxylaminates: A new series of hepatobiliary imaging agents.J Nucl Med 23: 517–524, 1982.
Hasegawa Y, Nakano K, Ibuka T, Hashizume Y, Sasaki S, Imaoka S, et al. Concentration of99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatoma.Eur J Nucl Med 10: 255–258, 1985.
Cavlet X, Pons F, Bruix J, Bru C, Lomena F, Herranz R, et al. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.J Nucl Med 29: 1916–1920, 1988.
Stadalnik RC, Vera DR, Woodle ES, Trudeau WL, Porter BA, Ward RE, et al. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.J Nucl Med 26: 1233–1242, 1985.
Wu J, Ishikawa N, Takeda T, Tanaka Y, Pan XQ, Sato M, et al. The functional hepatic volume assessed by99mTc-GSA hepatic scintigraphy.Ann Nucl Med 9: 229–235, 1995.
Kurtaran A, Li S-R, Radere M, Leimer M, Muller C, Pidlich J, et al. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-try-(A14)-insulin visualizes human hepatocellular carcinomas.J Nucl Med 36: 1875–1881, 1995.
Hyodo I, Mizuno M, Yamada G, Tsuji T. Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma.Liver 13: 80–85, 1993.
Matsui O Kadoya M, Kaneyama T, Yoshikawa J, Takashima T, Nakamura Y, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.Radiology 178: 493–497, 1991.
Conway JG, Popp JA, Thurman RG. Microcirculation of hepatic nodules from diethylnitrosamine-treated rats.Cancer Res 45: 3620–3625, 1985.
Yamashita Y, Matsukawa T, Arakawa A, Hatanaka Y, Urata J, Takahashi M. US-guided liver biopsy: predicting the effect of interventional treatment of hepatocellular carcinoma.Radiology 196: 799–804, 1995.
Shimada M, Takenaka K, Kawahara N, Yamamoto K, Shirabe K, Maehara Y, et al. Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopahological factors.Hepatogastroenterology 43: 1159–1164, 1996.
Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.Liver 7: 18–26, 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanabe, Y., Hashimoto, M., Ohuchi, Y. et al. Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions. Ann Nucl Med 14, 485–488 (2000). https://doi.org/10.1007/BF02988296
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02988296